Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE(−/−) Mice

por Gu, Lili, Gong, Yaqin, Zhao, Cheng, Wang, Yue, Tian, Qinghua, Lei, Gaoxin, Liang, Yalin, Zhao, Wenfeng, Tan, Shuhua
Publicado 2019

Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo

por Gu, Lili, Wang, Yue, Xu, Yaqiong, Tian, Qinghua, Lei, Gaoxin, Zhao, Cheng, Gao, Zhan, Pan, Qin, Zhao, Wenfeng, Nong, Liu, Tan, Shuhua
Publicado 2017

A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo

por Lei, Gaoxin, Xu, Menglong, Xu, Zhipan, Gu, Lili, Lu, Chenchen, Bai, Zhengli, Wang, Yue, Zhang, Yongbo, Hu, Huajing, Jiang, Yiwei, Zhao, Wenfeng, Tan, Shuhua
Publicado 2017

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy

por Xu, Menglong, Lei, Gaoxin, Chen, Manman, Wang, Ke, Lv, Wenxiu, Zhang, Panpan, Hu, Tuo, Gao, Jie, Lu, Chenchen, Mei, Ying, Xu, Zhipan, Bai, Zhengli, Hu, Huajing, Jiang, Yiwei, Tan, Shuhua
Publicado 2021